All articles by Venugopal Immadi
Venugopal Immadi
Similar experiences: challenges involved with biosimilars
Jeff Yant, executive director of global operations at Amgen Biosimilars, discusses the
challenges of producing and managing biosimilars. He talks to Sally Turner about supply
chain management strategies and explores key considerations for storage, packaging
and maintaining temperature control and oversight during transit.
Favourable comparisons: comparators and the pharma industry
Clinical Trials Insight looks at ways to share strategies used to acquire blinded comparators for global trials, and outlines how the industry is attempting to share the burden of costs.
Best practice: solid risk management plan
As highlighted by a fatal clinical trial in France in 2016, good pharmacovigilance is paramount for drug companies. That means a solid risk management plan, as Sini Eskola, director of regulatory affairs at the European Federation of Pharmaceutical Industries and Associations, tells Ross Davies.
A penny saved: clinical supplies funding
Finding the right balance of funding in an age of shrinking budgets is a tightrope walk that could easily set a clinical trial back. Andrew Putwain speaks to Didier Basseras, vice-president of clinical supplies at Sanofi, about this issue and how best to tackle it.